Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor. Singh SB, McLearn-Montz AJ, Milavetz F, Gates LK, et al. Pediatr Pulmonol 2019;54:1200-1208.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Singh SB, McLearn-Montz AJ, Milavetz F, Gates LK, et al. Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor. Pediatr Pulmonol 2019;54:1200-1208.
PMID: 31012285